Getting latest data loading
Home / Blog

Subscribe


 

Thomas Cook – No holiday from bad news

Just two days before it was scheduled to publish full year results Thomas Cook delivers yet another profits warning. The first two pushed the shares -74% from 2018’s 150p peak to its 39p trough. Today’s hat-trick-maker has lopped off another 20% (-32% at day lows ), undoing some of the late October bounce above 50p, putting…

The UK Index this week – 23 Nov

After a brief flirt, Wednesday, with the ceiling of November’s falling channel (7065), the UK Index is on the back foot into the weekend. Losses from the heavyweight Oil majors and Miners are overpowering the strength from a selection of Defensives (tobacco, pharma, telecoms) and high-street Banks (Lloyds and HSBC). The Pound Sterling has been both…

‘Tis the season for a Santa rally?

It’s that time of year again, when we refresh our statistics and take another look at the year-end phenomenon known as the Santa rally. The bullish theory holds that equities tend to rally in December, fuelled by a combination of window-dressing by portfolio managers, holiday-thinned trading volumes and self-fulfilling prophecy. Our latest report looks at…

Fresnillo: finding the silver lining

Silver miner Fresnillo trades fresh 2018 lows after a 12% share price plunge Thursday and another 7% today. Why? Analysts at Morgan Stanley downgraded it to Underweight and cut their target to 715p (from 1100p). Why? A series of bills in the Mexican parliament that could restrict mining. This highlights a glaring issue for long-term…

RBS: The Return of the King

Many investors assume that all UK Index Banks are the same and their share prices move in lockstep. Invest in one, invest in the other, what’s the difference? Today is a great example of a trading session that proves nothing could be further from the truth. Some of the blue-chip Banks are rallying (RBS), others…

BTG – Boston Takeover Gift

Another day, another takeover, with a handsome 35% share price jump to boot. And today its the turn of specialty healthcare/biotech company BTG which could be snapped up by Boston Scientific after it offered 840p cash per share (36% premium). BTG operates via 3 segments; interventional medicine (oncology (cancer), vascular, pulmonology), pharmacuticals and licensing, and has been formed…

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.